Ashish Tripathi is currently leading a groundbreaking molecular diagnostics company through its global commercialization phase, building on major scientific breakthroughs in precision medicine. His career bridges two distinct yet complementary worlds: cutting-edge healthcare innovation and global finance expertise.

With more than 20 years at leading financial institutions including Deutsche Bank, Edelweiss, and EY across five continents, he has executed complex M&A deals and crafted growth strategies for healthcare and technology companies. This unique blend of investment banking rigor and scientific commercialization experience enables him to drive transformative medical innovations to market.

Having led transactions and operations across North America, Europe, Asia, Australia, and the Middle East, he brings a truly global perspective to scaling healthcare ventures that improve lives worldwide.